Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

A gauge of the U.S. equities that equally weights stocks in the S&P 500 index was clinging to a slight gain on Friday afternoon. The Invesco S&P 500 Equal Weight ETF was up 0.1% in afternoon trading, ...

Informatica shares are down 49% in the last 12 months, compared with the S&P 500 index's SPX gain of 22.4%. Shares of rival International Business Machines Corp. (IBM) are up 39.3% in the last 12 ...

The persistent rise in US equities is helping promote a view that the relationships of old for stocks and traditional measures for value-oriented investing strategies no longer apply.

Choreo LLC increased its stake in FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 12.0% in the fourth quarter, ...

CBRE Group posted strong fourth-quarter earnings for 2024, surpassing analyst expectations and demonstrating solid segment performance.

AI is still a nascent part of Moody's business, but the early indicators point to success for company. That makes the stock a terrific opportunity to buy hand over fist. Investors with a long-run ...

On Wednesday the Labor Department is expected to report that in January the consumer price index rose 2.9% from a year ago, ...

New FactSet research breaks down the asset classes and categories that drove new ETF launches, with a short detour into why ...